Kymera Therapeutics Inc. (KYMR)
NASDAQ: KYMR
· Real-Time Price · USD
42.59
-1.03 (-2.36%)
At close: Aug 19, 2025, 3:59 PM
42.57
-0.05%
After-hours: Aug 19, 2025, 04:25 PM EDT
Kymera Therapeutics Revenue
Kymera Therapeutics reported an annual revenue of $47.07M, reflecting a -40.11% growth. For the quarter ending June 30, 2025, Kymera Therapeutics generated $11.48M in revenue.
Revenue (ttm)
47.07M
Revenue Growth
-40.11%
Price / Sales Ratio
64.14
Revenue / Employee
226.31K
Employees
208
Market Cap
3.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 47.07M | -40.11% |
| Dec 31, 2023 | 78.59M | +67.84% |
| Dec 31, 2022 | 46.83M | -35.71% |
| Dec 31, 2021 | 72.83M | +114.00% |
| Dec 31, 2020 | 34.03M | +1059.99% |
| Dec 31, 2019 | 2.93M | +Infinity% |
| Dec 31, 2018 | 0 | n/a |